Abstract：Objective: To explore the clinical value of dual-phase 99mTc-sestamibi(MIBI) scintigraphy and SPECT/CT imaging in diagnosing secondary hyperparathyroidism. Methods: Retrospectively analyzed the image features of dual-phase 99mTc-MIBI scintigraphy and SPECT/CT of 38 patients with secondary hyperparathyroidism, which were confirmed by postoperative pathology. Results: The sensitivity of 99mTc-MIBI scintigraphy and SPECT/CT in diagnosing secondary hyperthyroidism was 86.52% and 95.74% respectively. There were significant difference between dual-phase 99mTc-MIBI scintigraphy and SPECT/CT. Conclusions: Preoperative 99mTc-MIBI SPECT/CT imaging is significantly better than dual-phase 99mTc-MIBI scintigraphy in evaluating secondary hyperparathyroidism. 99mTc-MIBI SPECT/CT imaging is an ideal examination method for secondary hyperparathyroidism in preoperative location.
陈正国，刘启榆，吴春燕，陈 娇，何川东. SPECT/CT融合显像在继发性甲状旁腺功能亢进症中的临床价值[J]. 中国临床医学影像杂志, 2019, 30(3): 169-173.
CHEN Zheng-guo, LIU Qi-yu, WU Chun-yan, CHEN Jiao, HE Chuan-dong. The diagnostic value of 99mTc-sestamibi SPECT/CT in secondary hyperparathyroidism. JOURNAL OF CHINA MEDICAL IMAGING, 2019, 30(3): 169-173.
[1]Neyer U, Hoerandner H, Haid A, et al. Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection[J]. Nephrol Dial Transplant, 2002, 17(4): 625-629.
[2]Puccinil M, Ceccarelli C, Meniconi O, et al. Near total parathyroidectomy for the treatment of renal hyperparathyroidism[J]. Gland Surg, 2017, 6(6): 638-643.
[3]Chen J, Wang JD. Radioguided parathyroidectomy in patients with secondary hyperparathyroidism due to chronic renal failure[J]. Nucl Med Commun, 2014, 35(4): 391-397.
[4]Johnson NA, Carty SE, Tublin ME. Parathyroid imaging[J]. Radiol Clin North Am, 2011, 49(3): 489-509.
[5]Coakley AJ, Kettle AG, Well CP, et al. 99mTc sestamibi——a new agent for parathyroid imaging[J]. Nucl Med Commun, 1989, 10(11): 791-794.
[6]Hetrakul N, Civelek AC, Stagg CA, et al. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria[J]. Surgery, 2001, 130(6): 1011-1018.
[7]Moralidis E. Radionuclide parathyroid imaging: a concise, updated review[J]. Hell J Nucl Med, 2013, 16(2): 125-133.
[8]Chroustova D, Kubinyi J, Trnka J, et al. The role of 99mTc-MIBI SPECT/CT low dose CT with 3D in subtraction in patients with secondary hyperparathyroidism due to chronic kidney disease[J]. Endocr Regulations, 2014, 48(2): 55-63.
[9]Taieb D, Hindie E, Grassetto G, et al. Parathyroid scintigraphy: When, how, and why? A concise systematic review[J]. Clin Nucl Med, 2012, 37(6): 568-574.
[10]Burke JF, Naraharisetty K, Schneider DF, et al. Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism[J]. Am J Surg, 2013, 205(3): 269-273.
[11]Pons F, Torregrosa JV, Fuster D. Biological factors influencing parathyroid localization[J]. Nucl Med Commun, 2003, 24(2): 121-124.
[12]Xue JJ, Liu Y, Yang DR, et al. Dual-phase 99mTc-MIBI imaging and the expressions of P-gp, GST-π, and MRP1 in hyperparathyroidism[J]. Nucl Med Commun, 2017, 38(10): 868-874.
[13]Hayakawa N, Nakamoto Y, Kurihara K, et al. A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia[J]. Nucl Med Commun, 2015, 36(1): 53-59.
[14]Schachter PP, Issa N, Shimonov M, et al. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy[J]. Arch Surg, 2004, 139(4): 433-437.
[15]陈正国，刘启榆，陈娇，等. 99mTc-MIBI核素显像与CT在原发性甲状旁腺功能亢进症中的诊断价值[J]. 中国临床医学影像杂志，2016，27（4）：239-242.
[16]Mizamtsidi M, Nastos C, Mastorakos G, et al. Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks[J]. Endocr Connections, 2018, 7(2): R56-R68.
[17]Ryhnen EM, Schildt J, Heiskanen I, et al. 99mTechnetium sestamibi-123iodine scintigraphy is more accurate than 99mTechnetium sestamibi alone before surgery for primary hyperparathyroidism[J]. Intern J Mol Imaging, 2015, 2015: 391625.
[18]Kluijfhout WP, Pasternak JD, Drake FT, et al. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis[J]. Langenbecks Arch Surg, 2016, 401(7): 925-935.
[19]Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for SPECT/CT imaging 1.0[J]. J Nucl Med, 2006, 47(7): 1227-1234.
[20]Taieb D, Urena-Torres P, Zanotti-Fregonara P, et al. Parathyroid scintigraphy in renal hyperparathyroidism: the added diagnostic value of SPECT and SPECT/CT[J]. Clin Nucl Med, 2013, 38(8): 630-635.
[21]Taubman ML, Goldfarb M, Lew JI. Role of SPECT/CT in the surgical treatment of primary hyperparathyroidism[J]. Int J Mol Imaging, 2011, 2011: 141593.
[22]Monzen Y, Tamura A, Okaki H, et al. SPECT/CT fusion in the diagnosis of hyperparathyroidism[J]. Asia Ocean J Nucl Med Biol, 2015, 3(1): 61-65.
[23]Serra A, Bolasco P, Satta L, et al. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients[J]. Radiol Med, 2006, 11(7): 999-1008.
[24]Phitayakorn R, Mchenry CR. Incidence and location of ectopic abnormal parathyroid glands[J]. Am J Surg, 2006, 191(3): 418-423.
[25]Hamidi S, Soltani A, Hedayat A, et al. Primary hyperpara-thyroidism: a review of 177 cases[J]. Med Sci Monit, 2006, 12(2): 86-89.
